The Life Sciences Report

Home
The Life Sciences Report

News & investing ideas in biotech, pharmaceuticals, medical devices, nutraceuticals, tools & diagnostics & more. www.StreetwiseReports.com

Investors rely on Streetwise Reports to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends. This valuable insight is integrated with in-depth company information, summaries from the latest r

esearch and news that will help you make smart investment decisions. The Gold Report -
Featuring investment ideas in precious metals, critical metals and base metals. The Energy Report -
Featuring investment ideas in fossil fuels, nuclear power and alternative energy. The Life Sciences Report -
Featuring investment ideas in biotechnology, pharmaceuticals, medical devices, tools and diagnostics. The Mining Report -
Featuring investment ideas in energy, metals and mining. Get the newsletters for FREE - sign up here: http://www.streetwisereports.com

Streetwise Reports —"Where Successful Investors Go for Investment Ideas"—are a portfolio of industry-specific websites (The Gold Report, The Life Sciences Report and The Energy Report) and e-newsletters that feature top Wall Street analysts, leading portfolio managers and recognized newsletter writers giving their outlook on specific investment sectors and recommendations for companies in those sectors. In addition, the sites feature investment summaries on key companies within those industries. The Streetwise mission is to provide investors with expert perspectives so they can make more informed investment decisions. Streetwise Reports LLC is a privately held company headquartered in Sonoma County, California.

31/12/2025

Clean-Tech Co. Looks Forward to Massive Market Breakthroughs in 2026
https://ow.ly/ammi50XQILX

BioLargo Inc.'s ($BLGO:OTCQX) President and Chief Executive Officer Dennis P. Calvert notes the company is looking forward to its part in "what may be one of the largest infrastructure and technology investment cycles in history."

BioLargo Inc.'s (BLGO:OTCQX) President and Chief Executive Officer Dennis P. Calvert notes the company is looking forward to its part in what may be one of the largest infrastructure and technology investment cycles in history.

31/12/2025

Clean-Tech Firm Anticipates Major Market Advancements in 2026
https://ow.ly/OpOv50XQIr4

Dennis P. Calvert, President and CEO of BioLargo Inc. ($BLGO:OTCQX), mentions that the company is eager to participate in "what may be one of the largest infrastructure and technology investment cycles in history."

Dennis P. Calvert, President and CEO of BioLargo Inc. (BLGO:OTCQX), mentions that the company is eager to participate in what may be one of the largest infrastructure and technology investment cycles in history.

16/12/2025

Mineral Investor Chen Lin Argues Silver Moving From Bullion to Physical Asset, Reveals Picks
https://ow.ly/AqbU50XKujH

Seasoned minerals investor Chen Lin argues silver's 50-year breakout is not a routine cycle but a transition from bullion to a tightening "critical minerals" market. Read on to see what some of his top picks are, including one biotech company he thinks could be the next Eli Lilly.

Seasoned minerals investor Chen Lin argues silver's 50-year breakout is not a routine cycle but a transition from bullion to a tightening critical minerals market. Read on to see what some of his top picks are, including one biotech company he thinks could be the next Eli Lilly.

15/12/2025

Market Experts Uncover Excellent Buys During December 'Silly Season' Tax Selloff
https://ow.ly/MhcY50XJUaI

Every December, tax-loss selling tends to exert downward pressure on certain stocks as investors aim to offset capital gains. Streetwise Reports asked some of its frequent contributors to add their own thoughts on the other "holiday season" and give their own picks for good bargains.

$EMO.V $EMOTF $CDE Emerita Resources Corp.

Every December, tax-loss selling tends to exert downward pressure on certain stocks as investors aim to offset capital gains. Streetwise Reports asked some of its frequent contributors to add their own thoughts on the other holiday season and give their own picks for good bargains.

11/12/2025

Tech Firm Partners to Advance AI-Powered Support for MDs
https://ow.ly/bEyP50XHBUh

Rocket Doctor AI Inc.'s ($AIDR.CN; $TREIF:OTC; 939:FRA) Clinical Decision Support System is being deployed in Alberta, Canada, on a small scale for a trial period with the goal of expanding it province-wide next year. This company's stock is rated Speculative Buy; read on to learn why.

Rocket Doctor AI Inc.'s (AIDR:CSE; TREIF:OTC; 939:FRA) Clinical Decision Support System is being deployed in Alberta, Canada, on a small scale for a trial period with the goal of expanding it province-wide next year. This company's stock is rated Speculative Buy; read on to learn why.

08/12/2025

Clean Tech Co.'s 'Forever Chemicals' Solution Featured in Industry Magazine
https://ow.ly/MfyI50XG1MB

BioLargo Inc. ($BLGO :OTCQX) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) is prominently featured in Chemical Engineering magazine for its advancements in electrostatic PFAS treatment technology. Find out why one expert likes this stock long-term.

BioLargo

BioLargo Inc. (BLGO:OTCQX) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) is prominently featured in Chemical Engineering magazine for its advancements in electrostatic PFAS treatment technology. Find out why one expert likes this stock long-term.

08/12/2025

AI-Powered Healthcare Co. Gains Traction as US Expansion Accelerates
https://ow.ly/zQu850XG1L6

John Newell of John Newell & Associates shares why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.

John Newell of John Newell & Associates shares why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.

08/12/2025

Water Treatment Firm Finds High-Performance Solution for $2.99B PFAS Market
https://ow.ly/7RLp50XFW5Z

Chemical Engineering magazine features BioLargo Inc. (OTCQX: $BLGO) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) for its advancements in electrostatic PFAS treatment technology. Read why one expert likes this stock long-term.

BioLargo

Chemical Engineering magazine features BioLargo Inc. (OTCQX:BLGO) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) for its advancements in electrostatic PFAS treatment technology. Read why one expert likes this stock long-term.

04/12/2025

Data on 2 Drugs, Identified Via AI, Shared at Conference
https://ow.ly/5GbW50XC4Sg

Rakovina Therapeutics Inc.'s ($RKV.V) preclinical ATR inhibitors, Compound A and Compound C, exhibit similarities to two clinical-stage drugs in the same class, noted a Leede Financial Inc. report.

Rakovina Therapeutics Inc.'s (RKV:TSX.V) preclinical ATR inhibitors, Compound A and Compound C, exhibit similarities to two clinical-stage drugs in the same class, noted a Leede Financial Inc. report.

03/12/2025

AI Breakthroughs Drive New Momentum in Oncology Research
https://ow.ly/cPGr50XBt3W

Rakovina Therapeutics Inc. ($RKV.V) reported financial and operational results for Q3, detailing continued progress across its AI-enabled DNA Damage Response programs. The company highlighted new scientific data, expanded collaborations, and increased visibility at major oncology conferences.

Rakovina Therapeutics Inc. (RKV:TSX.V) reported financial and operational results for Q3, detailing continued progress across its AI-enabled DNA Damage Response programs. The company highlighted new scientific data, expanded collaborations, and increased visibility at major oncology conferences.

02/12/2025

Analyst: Scientific Instrument Co.'s Q3/25 Results 'Soft'
https://ow.ly/xZ6x50XASoX

Nanalysis Scientific Corp. ($NSCI.V; $NSCIF:OTC; 1N1:FSE) has its price target lowered as a result, but is expected to improve its financials in the near term, noted a Leede Financial Inc. report.

Nanalysis Scientific Corp. (NSCI:TSX.V; NSCIF:OTC; 1N1:FSE) has its price target lowered as a result, but is expected to improve its financials in the near term, noted a Leede Financial Inc. report.

01/12/2025

Biotech Co. Advances Precision Psychiatry Breakthrough Pipeline While Analysts' Sentiment Remains Positive
https://ow.ly/blgY50XAfJN

Alto Neuroscience Inc. ($ANRO:NYSE) continues moving its clinical programs forward, receives regulatory clarity and raises US$50 million, during the past four months. Read on for analysts' thoughts on this biopharma.

Alto Neuroscience Inc. (ANRO:NYSE) continues moving its clinical programs forward, receives regulatory clarity and raises US$50 million, during the past four months. Read on for analysts' thoughts on this biopharma.

Address

Website

http://www.TheLifeSciencesReport.com/

Alerts

Be the first to know and let us send you an email when The Life Sciences Report posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Life Sciences Report:

Want your business to be the top-listed Media Company?

Country:

City: